Skip to content

Long-term prognosis and risk assessment in idiopathic ventricular fibrillation including Brugada syndrome

Long-term prognosis and risk assessment in idiopathic ventricular fibrillation including Brugada syndrome - Japan Idiopathic Ventricular Fibrillation Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000024061
Enrollment
500
Registered
2016-09-18
Start date
2002-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic ventricular fibrillation including Brugada syndrome

Interventions

None listed

Sponsors

Japan Idiopathic Ventricular Fibrillation Study
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with idiopathic ventricular fibrillation including Brugada syndrome

Exclusion criteria

Exclusion criteria: Patients with ventricular fibrillation due to reversible causes or underlying structural heart diseases.

Design outcomes

Primary

MeasureTime frame
Incidence of sudden cardiac death and/or ventricular fibrillation (including ICD-documented ventricular fibrillation)

Secondary

MeasureTime frame
Assessment of risk factors for cardiac events in clinical, electrocardiac, and electrophysiologic characteristics

Countries

Japan

Contacts

Public ContactYukio Sekiguchi

Japan Idiopathic Ventricular Fibrillation Study Secretary general

j-ivfs@md.tsukuba.ac.jp029-853-3142

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026